Cancer is currently ineffectively treated using therapeutic drugs, and is also able to resist
drug action, resulting in increased side effects following drug treatment. A novel therapeutic …

Antimicrobial peptides (AMPs), or host defense peptides, are small cationic or amphipathic
molecules produced by prokaryotic and eukaryotic organisms that play a key role in the …

Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many
organisms. Although AMPs have been essentially studied and developed as potential …

Cancer is one of the leading causes of death worldwide. Conventional cancer therapies
mainly focus on mass cell killing without high specificity and often cause severe side effects …

Cancer is one of the leading causes of death worldwide. Conventional cancer treatment
relies on radiotherapy and chemotherapy, but both methods bring severe side effects to …

The innate immune response of insects provides a robust line of defense against pathogenic
microbes and eukaryotic parasites. It consists of two types of overlapping immune …

Here, we review potential determinants of the anticancer efficacy of innate immune peptides
(ACPs) for cancer cells. These determinants include membrane‐based factors, such as …

Many active principles produced by animals, plants and microorganisms have been
employed in the development of new drugs to treat diseases such as cancer. Among the …

The ultimate stage of the transmission of Dengue Virus (DENV) to man is strongly
dependent on crosstalk between the virus and the immune system of its vector Aedes …

Can antimicrobial activity and peptide stability of alpha-helical peptides be increased by
making them into dimers and macrocycles? Here, we explore that concept by using KR-12 …